Cutaneous Leishmaniasis Completed Phase 2 / 3 Trials for Paromomycin (DB01421)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03096457Topical Paromomycin for Cutaneous Leishmaniasis in BoliviaTreatment